"Novel targeted therapy combinations to improve efficacy in BRAF and KRAS mutant cancers," Ryan Corcoran, MD, PhD

Thursday, January 3, 2013 at 3:00pm to 4:00pm

Dana-Farber Cancer Institute, Dana 1620 Dana-Farber Cancer Institute, Boston, MA, Boston, MA

The DFCI Division of Molecular and Cellular Oncology presents a special seminar by Ryan Corcoran. His talk is titled "Novel targeted therapy combinations to improve efficacy in BRAF and KRAS mutant cancers"

Recent Activity

People Going

Getting Here


NCI CCC